Veoneer (VNE) Reports Q3 Loss of $0.78/Share

Veoneer (NYSE: VNE) reported Q3 EPS of ($0.78), versus ($0.38) reported last year. Revenue for the quarter came in at $526 million, versus $567 million reported last year.

Outlook and Targets Update

• FY’18 Consolidated Net Sales growth (4)%
• Q4’18 RD&E increase ~$20 million from Q3’18 levels
• Downside risk to 2020 total Sales target, Active Safety on-track
• 1 to 2 year delay to achieve 0 to 5% Operating Income target
• Upside potential to 2022 total Sales target, mainly Active Safety
  

For earnings history and earnings-related data on Veoneer (VNE) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c